Ptc Therapeutics, Inc. · NASDAQ:PTCT
Camber Capital Management LP's stake in Ptc Therapeutics, Inc. fell to 4.15% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Camber Capital Management LP's stake in Ptc Therapeutics, Inc. fell to 4.15%, 3,200,000 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 4.15%
- Shares
- 3,200,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Camber Capital Management LP | 4.15% | 3,200,000 |
| Stephen DuBois | 4.15% | 3,200,000 |
Source
Related
- Ptc Therapeutics, Inc.
- Camber Capital Management LP
- Ptc Therapeutics, Inc. shareholders
- Form 4 · Schmertzler Michael · Oct 16, 2026
- Form 4 · Boulding Mark Elliott · Oct 13, 2026
- Form 4 · Schmertzler Michael · Oct 9, 2026
- Form 4 · Boulding Mark Elliott · Oct 7, 2026
- Form 4 · Steele Glenn Jr Md Phd · Oct 2, 2026